2-(2-oxypyrrolidin-1-yl)-N-(2,3-dimethyl-5,6,7,8-tetrahydrofuro(2,3-b)quinolin-4-yl)acetoamide,
MKC 231,
MKC-231,
Coluracetam,
135463-81-9,
N-(2,3-dimethyl-5,6,7,8-tetrahydrofuro[2,3-b]quinolin-4-yl)-2-(2-oxopyrrolidin-1-yl)acetamide,
MKC-231,
bci-540,
UNII-V6FL6O5GR7,
V6FL6O5GR7,
AK-41975,
Coluracetam [INN],
MKC 231,
N-(2,3-Dimethyl-5,6,7,8-tetrahydrofuro(2,3-b)quinolin-4-yl)-2-(2-oxopyrrolidin-1-yl)acetamide,
AC1L4WO1,
CHEMBL37935,
SCHEMBL194780,
ZINC4939,
CTK8D3778,
KS-00000OFA,
DTXSID60159386,
EX-A739,
Coluracetam;MKC-231;BCI-540,
BCP07168,
AN-469,
MFCD00901416,
AKOS015842255,
CS-2196,
NCGC00378715-01,
2-(2-Oxypyrrolidin-1-yl)-N-(2,3-dimethyl-5,6,7,8-tetrahydrofuro(2,3-b)quinolin-4-yl)acetoamide,
AJ-08232,
DS-14004,
HY-17553,
AX8209310,
ST2407347,
TC-072260,
4CH-017490,
FT-0697594,
Y1294,
463C819,
J-690145,
I14-13061,
1-Pyrrolidineacetamide, 2-oxo-N-(5,6,7,8-tetrahydro-2,3-dimethylfuro(2,3-b)quinolin-4-yl)-,
N-(2,3-dimethyl-5,6,7,8-tetrahydrofuro[2,3-b]quinolin-4-yl)-2-(2-oxo-1-pyrrolidinyl)acetamide,
N-{2,3-DIMETHYL-5H,6H,7H,8H-FURO[2,3-B]QUINOLIN-4-YL}-2-(2-OXOPYRROLIDIN-1-YL)ACETAMIDE,
Tazemetostat,
D01MHI,
C19H23N3O3,
CID214346,
ACN-028798,
B1158,
A13516,
High-affinity choline uptake facilitator (CNS disorders), Mitsubishi,
High-affinity choline uptake facilitator (depression/ anxiety), BrainCells,
Neurons growth promoting compound (major depressive disorder/anxiety), BrainCells,
1-Pyrrolidineacetamide, 2-oxo-N-(5,6,7,8-tetrahydro-2,3-dimethylfuro[2,3-b]quinolin-4-yl)-,